Simplex Trading’s Bio-Path Holdings Inc BPTH Stock Holding History

Simplex Trading’s Portfolio BPTH Stock Details BPTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1	Closed	–	–	10468
2022 Q4	$0	Buy	+1	New	+$44	﹤0.01%	10801

Other funds holding BPTH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MYIA

Mount Yale Investment Advisors Denver, Colorado $4.31B AUM 21.13% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Simplex Trading's BPTH Position: Q1 2023 in Review

Simplex Trading sold out of Bio-Path Holdings Inc (BPTH) in Q1 2023, closing a stake of 1 share.

Simplex Trading first reported a position in BPTH in Q4 2022 and held it in 1 quarter. The position peaked at $0 in Q4 2022. 21 funds tracked by Wall St. Rank hold BPTH as of Q1 2023.

Simplex Trading reported no remaining Bio-Path Holdings Inc position as of Q1 2023 after selling out during the quarter.
Simplex Trading sold 1 Bio-Path Holdings Inc share in Q1 2023.
Simplex Trading first reported a position in Bio-Path Holdings Inc in Q4 2022 and held it in 1 quarter.
Simplex Trading's Bio-Path Holdings Inc position peaked at $0 in Q4 2022.
21 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q1 2023.

Based on Simplex Trading's 13F filing for Q1 2023, filed 27 Apr 2023.